Finance

Lists
KNE:CVE
Kane Biotech Inc
CA$0.030
0.00%
(0.00) 1D
Oct 1, 2:09:12 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for KNE...
Mkt. cap
6.16M
Avg. vol.
38.35K
Volume
800.00
52-wk high
CA$0.04
52-wk low
CA$0.02
EPS
-CA$0.02
Beta
0.27
Shares outstanding
205.06M
Mkt. cap
6.16M
Avg. vol.
38.35K
Volume
800.00
52-wk high
CA$0.04
52-wk low
CA$0.02
EPS
-CA$0.02
Beta
0.27
Shares outstanding
205.06M
News stories
From web sources and news partners
About Kane Biotech Inc
CEO-
Employees-
Founded2001
HeadquartersWinnipeg, Manitoba, Canada
SectorBiotechnology
Websitekanebiotech.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.50K
-21.14K
43.22K
8.14K
Cost of goods sold
13.63K
-28.71K
47.12K
6.70K
Cost of revenue
13.63K
-28.71K
47.12K
6.70K
Research and development expenses
159.64K
114.94K
208.80K
114.09K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
378.67K
522.13K
460.61K
671.84K
Operating expense
538.31K
637.07K
669.40K
785.93K
Total operating expenses
551.93K
608.36K
716.52K
792.63K
Operating income
-543.43K
-629.50K
-673.30K
-784.48K
Other non operating income
-
-
-
-
EBT including unusual items
-607.34K
-654.86K
-710.60K
-829.78K
EBT excluding unusual items
-607.34K
-633.88K
-731.00K
-829.78K
Income tax expense
-
-108.00K
4.22K
3.86K
Effective tax rate
-
16.49%
-0.59%
-0.46%
Other operating expenses
-
-
-
-
Net income
-607.34K
-546.86K
-714.83K
-833.64K
Net profit margin
-7,146.08%
2,586.83%
-1,654.00%
-10,237.46%
Earnings per share
-
-
-
-
Interest and investment income
7.95K
1.81K
3.08K
3.38K
Interest expense
-71.86K
-10.14K
-57.88K
-47.00K
Net interest expenses
-63.91K
-8.33K
-54.80K
-43.61K
Depreciation and amortization charges
-
-
-
-
EBITDA
-445.94K
-614.14K
-654.30K
-771.44K
Gain or loss from assets sale
-
-27.01K
1.76K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps